Key result
Preoperative platelet reactivity unit values of 180-200 were associated with the likelihood of postoperative bleeding after CABGS, particularly on dual antiplatelet therapy.
Why the study?
Does preoperative Platelet Reactivity Unit (PRU) assessment predict the risk of postoperative bleeding in patients undergoing coronary artery bypass graft surgery?
Cohort (n=238)
Does preoperative Platelet Reactivity Unit (PRU) assessment predict the risk of postoperative bleeding in patients undergoing coronary artery bypass graft surgery?
Preoperative PRU values between 180-200 can help stratify the risk of postoperative bleeding in CABG patients, particularly those on dual antiplatelet therapy.
Answers are grounded in this paper and cite their sources.
May support preoperative PRU testing for bleeding risk stratification in CABG on DAPT; leaves open need for prospective validation.
Bleeding is a common complication of cardiac surgery, accounting for a significant proportion of the total transfusions performed in the United States and Europe. The relationship between platelet reactivity, bleeding, and other adverse events after coronary artery bypass graft surgery (CABGS) has been incompletely characterized. This study investigated the relationship between platelet reactivity and bleeding as a clinical outcome after successful CABGS. A total of 238 patients who underwent CABGS were retrospectively followed for postoperative bleeding. Platelet reactivity unit (PRU) values for all patients were obtained preoperatively to assess the platelet reactivity. The data showed that a range of 180-200 PRU suggests the likelihood of bleeding after CABGS (P = 0.004), with a statistically significant association only for dual antiplatelet therapy with aspirin and clopidogrel. In conclusion, by using PRU values as a method to assess platelet reactivity and antiplatelet responsiveness, our findings suggest that it may be possible to stratify patients undergoing CABGS for the risk of postoperative bleeding particularly patients on dual antiplatelet therapy.
No takes yet. Share an insight, caveat, or question.
Altheeb et al. (2015) conducted a cohort in Coronary artery bypass graft surgery (CABGS) (n=238). Preoperative platelet reactivity unit (PRU) values was evaluated on Postoperative bleeding (p=0.004). Preoperative platelet reactivity unit values of 180-200 were associated with the likelihood of postoperative bleeding after CABGS, particularly on dual antiplatelet therapy.
Synapse has enriched 10 related papers. Consider them for comparative context: